{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:46:31Z","timestamp":1791909991303,"version":"4.3.4"},"reference-count":193,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.hoc.2010.06.003","type":"journal-article","created":{"date-parts":[[2010,9,5]],"date-time":"2010-09-05T04:32:06Z","timestamp":1283661126000},"page":"885-906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Hereditary Genodermatoses with Cancer Predisposition"],"prefix":"10.1016","volume":"24","author":[{"given":"Meg R.","family":"Gerstenblith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa M.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/archderm.1951.01570010076006","article-title":"Epithelioma adenoides cysticum: basal cell nevi, agenesis of the corpus callosum and dental cysts: a clinical and autopsy study","volume":"63","author":"Binkley","year":"1951","journal-title":"AMA Arch Derm Syphilol"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archderm.1959.01560130069008","article-title":"The basal-cell nevus: its relationship to multiple cutaneous cancers and associated anomalies of development","volume":"79","author":"Howell","year":"1959","journal-title":"AMA Arch Derm"},{"key":"10.1016\/j.hoc.2010.06.003_bib3","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJM196005052621803","article-title":"Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome","volume":"262","author":"Gorlin","year":"1960","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2010.06.003_bib4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0140-6736(92)90868-4","article-title":"Location of gene for Gorlin syndrome","volume":"339","author":"Farndon","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2010.06.003_bib5","series-title":"GeneReviews","article-title":"Nevoid basal cell carcinoma syndrome","author":"Evans","year":"2008"},{"issue":"3","key":"10.1016\/j.hoc.2010.06.003_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M","article-title":"Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome","volume":"69","author":"Kimonis","year":"1997","journal-title":"Am J Med Genet"},{"issue":"20","key":"10.1016\/j.hoc.2010.06.003_bib7","first-page":"4599","article-title":"Mutations in the human homologue of the Drosophila patched gene in Caucasian and African-American nevoid basal cell carcinoma syndrome patients","volume":"56","author":"Chidambaram","year":"1996","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib8","first-page":"21","article-title":"Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident","volume":"60","author":"Wicking","year":"1997","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.hoc.2010.06.003_bib9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1046\/j.1523-1747.2003.12423.x","article-title":"Spectrum of PTCH1 mutations in French patients with Gorlin syndrome","volume":"121","author":"Boutet","year":"2003","journal-title":"J\u00a0Invest Dermatol"},{"issue":"5","key":"10.1016\/j.hoc.2010.06.003_bib10","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s004390050747","article-title":"The effects of splice site mutations in patients with naevoid basal cell carcinoma syndrome","volume":"102","author":"Smyth","year":"1998","journal-title":"Hum Genet"},{"issue":"6","key":"10.1016\/j.hoc.2010.06.003_bib11","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.GIM.0000144188.15902.C4","article-title":"Nevoid basal cell carcinoma (Gorlin) syndrome","volume":"6","author":"Gorlin","year":"2004","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib12","first-page":"12","article-title":"The nevoid basal cell carcinoma syndrome","volume":"19","author":"Anderson","year":"1967","journal-title":"Am J Hum Genet"},{"issue":"15","key":"10.1016\/j.hoc.2010.06.003_bib13","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/jnci\/89.15.1103","article-title":"Developmental genes and cancer: role of patched in basal cell carcinoma of the skin","volume":"89","author":"Gailani","year":"1997","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0196-85","article-title":"A\u00a0two-hit model for developmental defects in Gorlin syndrome","volume":"12","author":"Levanat","year":"1996","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.hoc.2010.06.003_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000018391","article-title":"Multiple familial basal cell carcinomas including a case of segmental manifestation","volume":"200","author":"Guarneri","year":"2000","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.hoc.2010.06.003_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/jmg.2007.055343","article-title":"A\u00a0missense mutation in PTCH2 underlies dominantly inherited NBCCS in a Chinese family","volume":"45","author":"Fan","year":"2008","journal-title":"J\u00a0Med Genet"},{"issue":"7","key":"10.1016\/j.hoc.2010.06.003_bib17","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/ajmg.a.32944","article-title":"Identification of a SUFU germline mutation in a family with Gorlin syndrome","volume":"149A","author":"Pastorino","year":"2009","journal-title":"Am J Med Genet A"},{"issue":"5268","key":"10.1016\/j.hoc.2010.06.003_bib18","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.272.5268.1668","article-title":"Human homolog of patched, a candidate gene for the basal cell nevus syndrome","volume":"272","author":"Johnson","year":"1996","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.hoc.2010.06.003_bib19","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0092-8674(00)81268-4","article-title":"Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome","volume":"85","author":"Hahn","year":"1996","journal-title":"Cell"},{"issue":"6900","key":"10.1016\/j.hoc.2010.06.003_bib20","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nature00989","article-title":"Patched acts catalytically to suppress the activity of Smoothened","volume":"418","author":"Taipale","year":"2002","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.hoc.2010.06.003_bib21","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1101\/gad.938601","article-title":"Hedgehog signaling in animal development: paradigms and principles","volume":"15","author":"Ingham","year":"2001","journal-title":"Genes Dev"},{"issue":"6662","key":"10.1016\/j.hoc.2010.06.003_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/34201","article-title":"Activating Smoothened mutations in sporadic basal-cell carcinoma","volume":"391","author":"Xie","year":"1998","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ng0996-78","article-title":"The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas","volume":"14","author":"Gailani","year":"1996","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.hoc.2010.06.003_bib24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ng916","article-title":"Mutations in SUFU predispose to medulloblastoma","volume":"31","author":"Taylor","year":"2002","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/1098-1004(200007)16:1<89::AID-HUMU18>3.0.CO;2-7","article-title":"Identification of PATCHED mutations in medulloblastomas by direct sequencing","volume":"16","author":"Dong","year":"2000","journal-title":"Hum Mutat"},{"issue":"9","key":"10.1016\/j.hoc.2010.06.003_bib26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/154405910608500916","article-title":"PTCH mutations in sporadic and Gorlin-syndrome-related odontogenic keratocysts","volume":"85","author":"Gu","year":"2006","journal-title":"J\u00a0Dent Res"},{"issue":"5","key":"10.1016\/j.hoc.2010.06.003_bib27","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ejmg.2008.04.002","article-title":"Prenatal manifestation in a family affected by nevoid basal cell carcinoma syndrome","volume":"51","author":"Le Brun Keris","year":"2008","journal-title":"Eur J Med Genet"},{"issue":"10","key":"10.1016\/j.hoc.2010.06.003_bib28","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1524-4725.2009.01279.x","article-title":"Photodynamic therapy for patients with Basal cell nevus syndrome","volume":"35","author":"Gilchrest","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.hoc.2010.06.003_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1158\/1940-6207.CAPR-09-0200","article-title":"Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+\/\u2212 humans and mice","volume":"3","author":"Tang","year":"2010","journal-title":"Cancer Prev Res (Phila Pa)"},{"issue":"5586","key":"10.1016\/j.hoc.2010.06.003_bib30","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1126\/science.1073733","article-title":"Medulloblastoma growth inhibition by hedgehog pathway blockade","volume":"297","author":"Berman","year":"2002","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.hoc.2010.06.003_bib31","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJMoa0902903","article-title":"Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449","volume":"361","author":"Rudin","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.hoc.2010.06.003_bib32","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1056\/NEJMoa0905360","article-title":"Inhibition of the hedgehog pathway in advanced basal-cell carcinoma","volume":"361","author":"Von Hoff","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"9368","key":"10.1016\/j.hoc.2010.06.003_bib33","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(03)13166-2","article-title":"Von Recklinghausen's neurofibromatosis: neurofibromatosis type 1","volume":"361","author":"Reynolds","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2008.12.051","article-title":"Neurofibromatosis type 1","volume":"61","author":"Boyd","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams","year":"2009","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.hoc.2010.06.003_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/sj.ejhg.5201676","article-title":"Neurofibromatosis 1","volume":"15","author":"Ferner","year":"2007","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"10.1016\/j.hoc.2010.06.003_bib37","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/archderm.1995.01690200040007","article-title":"Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis","volume":"131","author":"Zvulunov","year":"1995","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.hoc.2010.06.003_bib38","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/088307380201700808","article-title":"Neurofibromas in children with neurofibromatosis 1","volume":"17","author":"Rosser","year":"2002","journal-title":"J\u00a0Child Neurol"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/08820530701745223","article-title":"Neurofibromatosis type I: genetics and clinical manifestations","volume":"23","author":"Savar","year":"2008","journal-title":"Semin Ophthalmol"},{"issue":"3","key":"10.1016\/j.hoc.2010.06.003_bib40","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1378\/chest.06-3017","article-title":"Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy?","volume":"132","author":"Stewart","year":"2007","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.hoc.2010.06.003_bib41","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/00000478-200608000-00018","article-title":"Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient","volume":"30","author":"Perren","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.hoc.2010.06.003_bib42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner","year":"2007","journal-title":"J\u00a0Med Genet"},{"issue":"18","key":"10.1016\/j.hoc.2010.06.003_bib43","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1158\/0008-5472.CAN-09-1752","article-title":"Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association","volume":"69","author":"Brems","year":"2009","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.hoc.2010.06.003_bib44","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/neu.480270408","article-title":"Regulated expression of neurofibromin in migrating neural crest cells of avian embryos","volume":"27","author":"Stocker","year":"1995","journal-title":"J\u00a0Neurobiol"},{"issue":"3","key":"10.1016\/j.hoc.2010.06.003_bib45","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0896-6273(92)90270-N","article-title":"The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes","volume":"8","author":"Daston","year":"1992","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib46","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ng0995-90","article-title":"Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene","volume":"11","author":"Colman","year":"1995","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00690419","article-title":"The Ras signal transduction pathway","volume":"13","author":"Khosravi-Far","year":"1994","journal-title":"Cancer Metastasis Rev"},{"issue":"11","key":"10.1016\/j.hoc.2010.06.003_bib48","doi-asserted-by":"crossref","first-page":"842","DOI":"10.7326\/0003-4819-144-11-200606060-00010","article-title":"Pathophysiology of neurofibromatosis type 1","volume":"144","author":"Theos","year":"2006","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.hoc.2010.06.003_bib49","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ng2113","article-title":"Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype","volume":"39","author":"Brems","year":"2007","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.hoc.2010.06.003_bib50","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N","article-title":"Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects","volume":"15","author":"Messiaen","year":"2000","journal-title":"Hum Mutat"},{"issue":"11","key":"10.1016\/j.hoc.2010.06.003_bib51","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1212\/WNL.56.11.1433","article-title":"The clinical and diagnostic implications of mosaicism in the neurofibromatoses","volume":"56","author":"Ruggieri","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.hoc.2010.06.003_bib52","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00439-003-1047-9","article-title":"Genetic and clinical mosaicism in a patient with neurofibromatosis type 1","volume":"114","author":"Vandenbroucke","year":"2004","journal-title":"Hum Genet"},{"issue":"2","key":"10.1016\/j.hoc.2010.06.003_bib53","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/(SICI)1096-8628(1997)73:2<197::AID-AJMG17>3.0.CO;2-P","article-title":"Familial neurofibromatosis 1 microdeletions: cosegregation with distinct facial phenotype and early onset of cutaneous neurofibromata","volume":"73","author":"Leppig","year":"1997","journal-title":"Am J Med Genet"},{"issue":"5","key":"10.1016\/j.hoc.2010.06.003_bib54","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/374821","article-title":"Elevated risk for MPNST in NF1 microdeletion patients","volume":"72","author":"De Raedt","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib55","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/510781","article-title":"An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation","volume":"80","author":"Upadhyaya","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib56","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1212\/01.WNL.0000042321.94839.78","article-title":"Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1","volume":"60","author":"Gupta","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.hoc.2010.06.003_bib57","first-page":"507","article-title":"Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas","volume":"24","author":"Widemann","year":"2006","journal-title":"Clin Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2010.06.003_bib58","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.mrrev.2008.06.001","article-title":"The mTOR pathway and its role in human genetic diseases","volume":"659","author":"Rosner","year":"2008","journal-title":"Mutat Res"},{"issue":"2","key":"10.1016\/j.hoc.2010.06.003_bib59","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ijc.24783","article-title":"Preclinical in vivo evaluation of rapamycin in human malignant peripheral nerve sheath explant xenograft","volume":"126","author":"Bhola","year":"2010","journal-title":"Int J Cancer"},{"issue":"6136","key":"10.1016\/j.hoc.2010.06.003_bib60","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/329246a0","article-title":"Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22","volume":"329","author":"Rouleau","year":"1987","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.hoc.2010.06.003_bib61","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0092-8674(87)90534-4","article-title":"Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene","volume":"49","author":"Seizinger","year":"1987","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.hoc.2010.06.003_bib62","first-page":"172","article-title":"National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987","volume":"1","year":"1988","journal-title":"Neurofibromatosis"},{"issue":"12","key":"10.1016\/j.hoc.2010.06.003_bib63","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/jmg.29.12.841","article-title":"A\u00a0genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity","volume":"29","author":"Evans","year":"1992","journal-title":"J\u00a0Med Genet"},{"issue":"9679","key":"10.1016\/j.hoc.2010.06.003_bib64","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0140-6736(09)60259-2","article-title":"Neurofibromatosis type 2","volume":"373","author":"Asthagiri","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.hoc.2010.06.003_bib65","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF00294370","article-title":"Distribution and immunoreactivity of cerebral micro-hamartomas in bilateral acoustic neurofibromatosis (neurofibromatosis 2)","volume":"79","author":"Wiestler","year":"1989","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.hoc.2010.06.003_bib66","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.ajo.2005.12.042","article-title":"Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2","volume":"141","author":"Bosch","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.hoc.2010.06.003_bib67","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/archopht.1990.01070050026011","article-title":"Retinal hamartoma in neurofibromatosis 2","volume":"108","author":"Landau","year":"1990","journal-title":"Arch Ophthalmol"},{"issue":"304","key":"10.1016\/j.hoc.2010.06.003_bib68","first-page":"603","article-title":"A\u00a0clinical study of type 2 neurofibromatosis","volume":"84","author":"Evans","year":"1992","journal-title":"Q\u00a0J Med"},{"issue":"12","key":"10.1016\/j.hoc.2010.06.003_bib69","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1001\/archderm.1997.03890480059008","article-title":"Skin abnormalities in neurofibromatosis 2","volume":"133","author":"Mautner","year":"1997","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.hoc.2010.06.003_bib70","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1056\/NEJM198803173181106","article-title":"Neurofibromatosis 2 (bilateral acoustic neurofibromatosis)","volume":"318","author":"Martuza","year":"1988","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.hoc.2010.06.003_bib71","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ajmg.1320520411","article-title":"Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity","volume":"52","author":"Parry","year":"1994","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.hoc.2010.06.003_bib72","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/jmg.29.12.847","article-title":"A\u00a0genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling","volume":"29","author":"Evans","year":"1992","journal-title":"J\u00a0Med Genet"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib73","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00129492-200501000-00016","article-title":"Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought","volume":"26","author":"Evans","year":"2005","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.hoc.2010.06.003_bib74","series-title":"GeneReviews","article-title":"Neurofibromatosis 2","author":"Evans","year":"2009"},{"issue":"4","key":"10.1016\/j.hoc.2010.06.003_bib75","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1086\/342716","article-title":"Predictors of the risk of mortality in neurofibromatosis 2","volume":"71","author":"Baser","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.hoc.2010.06.003_bib76","first-page":"529","article-title":"Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities","volume":"59","author":"Parry","year":"1996","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.hoc.2010.06.003_bib77","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jmg.35.6.450","article-title":"Genotype\/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations","volume":"35","author":"Evans","year":"1998","journal-title":"J\u00a0Med Genet"},{"issue":"2","key":"10.1016\/j.hoc.2010.06.003_bib78","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1086\/422700","article-title":"Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study","volume":"75","author":"Baser","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.hoc.2010.06.003_bib79","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/jmg.40.6.459","article-title":"Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring","volume":"40","author":"Moyhuddin","year":"2003","journal-title":"J\u00a0Med Genet"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib80","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/02688690500081206","article-title":"Management of the patient and family with neurofibromatosis 2: a consensus conference statement","volume":"19","author":"Evans","year":"2005","journal-title":"Br J Neurosurg"},{"issue":"4","key":"10.1016\/j.hoc.2010.06.003_bib81","first-page":"596","article-title":"Evidence of meningioma infiltration into cranial nerves: clinical implications for cavernous sinus meningiomas","volume":"83","author":"Larson","year":"1995","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib82","first-page":"20","article-title":"Petroclival meningiomas: surgical experience in 109 cases","volume":"84","author":"Couldwell","year":"1996","journal-title":"J\u00a0Neurosurg"},{"issue":"15","key":"10.1016\/j.hoc.2010.06.003_bib83","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1128\/MCB.01581-08","article-title":"NF2\/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth","volume":"29","author":"James","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.hoc.2010.06.003_bib84","first-page":"81","article-title":"Scl\u00e9rose tub\u00e9reuse des circonvolution c\u00e9r\u00e9brales: idiotie et \u00e9pidelpsie hemipl\u00e9gique","volume":"1","author":"Bourneville","year":"1880","journal-title":"Arch Neurol"},{"key":"10.1016\/j.hoc.2010.06.003_bib85","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","article-title":"Epidemiology of tuberous sclerosis","volume":"615","author":"Osborne","year":"1991","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"10.1016\/j.hoc.2010.06.003_bib86","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/088307389801301206","article-title":"Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria","volume":"13","author":"Roach","year":"1998","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.hoc.2010.06.003_bib87","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1749-6632.1991.tb37743.x","article-title":"Neuropsychiatric aspects of tuberous sclerosis","volume":"615","author":"Curatolo","year":"1991","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib88","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/ejpn.2001.0538","article-title":"Tuberous sclerosis complex: a review of neurological aspects","volume":"6","author":"Curatolo","year":"2002","journal-title":"Eur J Paediatr Neurol"},{"issue":"9","key":"10.1016\/j.hoc.2010.06.003_bib89","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/08830738040190090401","article-title":"Brain abnormalities in tuberous sclerosis complex","volume":"19","author":"DiMario","year":"2004","journal-title":"J\u00a0Child Neurol"},{"issue":"2","key":"10.1016\/j.hoc.2010.06.003_bib90","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/WCO.0b013e3280895d93","article-title":"Neuroimaging in tuberous sclerosis complex","volume":"20","author":"Luat","year":"2007","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"10.1016\/j.hoc.2010.06.003_bib91","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2009.02567.x","article-title":"Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature","volume":"16","author":"Adriaensen","year":"2009","journal-title":"Eur J Neurol"},{"issue":"9639","key":"10.1016\/j.hoc.2010.06.003_bib92","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.hoc.2010.06.003_bib93","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archneur.55.3.379","article-title":"Poor mental development in patients with tuberous sclerosis complex: clinical risk factors","volume":"55","author":"J\u00f3\u017awiak","year":"1998","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib94","first-page":"10","article-title":"Prognostic factors for mental retardation in patients with tuberous sclerosis complex","volume":"13","author":"Chou","year":"2004","journal-title":"Acta Neurol Taiwan"},{"issue":"6","key":"10.1016\/j.hoc.2010.06.003_bib95","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1464-410X.2004.05046.x","article-title":"An epidemiological study of renal pathology in tuberous sclerosis complex","volume":"94","author":"O'Callaghan","year":"2004","journal-title":"BJU Int"},{"issue":"9366","key":"10.1016\/j.hoc.2010.06.003_bib96","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0140-6736(03)13044-9","article-title":"Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma","volume":"361","author":"El-Hashemite","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib97","first-page":"141","article-title":"Renal lesion growth in children with tuberous sclerosis complex","volume":"160","author":"Ewalt","year":"1998","journal-title":"J\u00a0Urol"},{"issue":"10","key":"10.1016\/j.hoc.2010.06.003_bib98","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","article-title":"Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors","volume":"70","author":"Rakowski","year":"2006","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.hoc.2010.06.003_bib99","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9149(03)00677-5","article-title":"Association between cardiac tumors and tuberous sclerosis in the fetus and neonate","volume":"92","author":"Tworetzky","year":"2003","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.hoc.2010.06.003_bib100","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1067\/S0022-3476(03)00494-3","article-title":"Fetal rhabdomyoma: prenatal diagnosis, clinical outcome, and incidence of associated tuberous sclerosis complex","volume":"143","author":"Bader","year":"2003","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.hoc.2010.06.003_bib101","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaad.2007.05.004","article-title":"Tuberous sclerosis complex: advances in diagnosis, genetics, and management","volume":"57","author":"Schwartz","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/rmed.2001.1207","article-title":"Lymphangioleiomyomatosis: a review of the literature","volume":"96","author":"Hancock","year":"2002","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.hoc.2010.06.003_bib103","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/bjo.85.4.420","article-title":"Ophthalmic manifestations of tuberous sclerosis: a population based study","volume":"85","author":"Rowley","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.hoc.2010.06.003_bib104","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1749-6632.1991.tb37783.x","article-title":"Enamel pitting. A common sign of tuberous sclerosis","volume":"615","author":"Mlynarczyk","year":"1991","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.hoc.2010.06.003_bib105","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0030-4220(89)90162-X","article-title":"Oral fibromatosis in tuberous sclerosis","volume":"68","author":"Lygidakis","year":"1989","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archderm.1968.01610130007001","article-title":"White leaf-shaped macules. Earliest visible sign of tuberous sclerosis","volume":"98","author":"Fitzpatrick","year":"1968","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1016\/j.hoc.2010.06.003_bib107","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/088307380001501003","article-title":"Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients","volume":"15","author":"J\u00f3zwiak","year":"2000","journal-title":"J\u00a0Child Neurol"},{"issue":"6","key":"10.1016\/j.hoc.2010.06.003_bib108","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-2230.1985.tb00623.x","article-title":"The prevalence of caf\u00e9-au-lait patches in tuberous sclerosis","volume":"10","author":"Bell","year":"1985","journal-title":"Clin Exp Dermatol"},{"issue":"6 Pt 1","key":"10.1016\/j.hoc.2010.06.003_bib109","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0190-9622(99)70075-7","article-title":"The diagnostic value of caf\u00e9-au-lait macules","volume":"40","author":"Landau","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.hoc.2010.06.003_bib110","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/hmg\/7.6.1053","article-title":"Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products","volume":"7","author":"van Slegtenhorst","year":"1998","journal-title":"Hum Mol Genet"},{"issue":"Pt 1","key":"10.1016\/j.hoc.2010.06.003_bib111","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1469-1809.2003.00012.x","article-title":"Tuberous sclerosis: from tubers to mTOR","volume":"67","author":"Kwiatkowski","year":"2003","journal-title":"Ann Hum Genet"},{"issue":"15","key":"10.1016\/j.hoc.2010.06.003_bib112","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","article-title":"Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb","volume":"13","author":"Tee","year":"2003","journal-title":"Curr Biol"},{"issue":"R1","key":"10.1016\/j.hoc.2010.06.003_bib113","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1093\/hmg\/ddp032","article-title":"Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment","volume":"18","author":"Inoki","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10.1016\/j.hoc.2010.06.003_bib114","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1101\/gad.901101","article-title":"TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth","volume":"15","author":"Gao","year":"2001","journal-title":"Genes Dev"},{"issue":"3","key":"10.1016\/j.hoc.2010.06.003_bib115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0092-8674(01)00332-4","article-title":"The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation","volume":"105","author":"Tapon","year":"2001","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.hoc.2010.06.003_bib116","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0092-8674(01)00333-6","article-title":"Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size","volume":"105","author":"Potter","year":"2001","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.hoc.2010.06.003_bib117","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/138920208786241243","article-title":"Genetics and molecular biology of tuberous sclerosis complex","volume":"9","author":"Napolioni","year":"2008","journal-title":"Curr Genomics"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib118","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"Dabora","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.hoc.2010.06.003_bib119","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/302381","article-title":"Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis","volume":"64","author":"Jones","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.hoc.2010.06.003_bib120","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.ejhg.5201402","article-title":"Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype-phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex","volume":"13","author":"Sancak","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.003_bib121","series-title":"GeneReviews","article-title":"Tuberous sclerosis complex","author":"Northrup","year":"2009"},{"key":"10.1016\/j.hoc.2010.06.003_bib122","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jmg.38.5.347","article-title":"A\u00a0novel missense mutation in the GTPase activating protein homology region of TSC2 in 2 large families with tuberous sclerosis complex","volume":"38","author":"Khare","year":"2001","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.hoc.2010.06.003_bib123","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ana.21037","article-title":"Unusually mild tuberous sclerosis phenotype is associated with TSC2 R905Q mutation","volume":"60","author":"Jansen","year":"2006","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.hoc.2010.06.003_bib124","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1294-328","article-title":"Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease\u2014a contiguous gene syndrome","volume":"8","author":"Brook-Carter","year":"1994","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.hoc.2010.06.003_bib125","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1086\/514888","article-title":"Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene","volume":"61","author":"Sampson","year":"1997","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.hoc.2010.06.003_bib126","first-page":"1635","article-title":"The tuberous sclerosis complex and its highly variable manifestations","volume":"169","author":"Lendvay","year":"2003","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.hoc.2010.06.003_bib127","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/088307389901400610","article-title":"Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association","volume":"14","author":"Roach","year":"1999","journal-title":"J\u00a0Child Neurol"},{"issue":"2","key":"10.1016\/j.hoc.2010.06.003_bib128","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/088307389901400201","article-title":"Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review","volume":"14","author":"Hancock","year":"1999","journal-title":"J\u00a0Child Neurol"},{"issue":"2-3","key":"10.1016\/j.hoc.2010.06.003_bib129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0920-1211(99)00082-0","article-title":"Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients","volume":"38","author":"Jambaqu\u00e9","year":"2000","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.hoc.2010.06.003_bib130","first-page":"5645","article-title":"Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors","volume":"62","author":"Kenerson","year":"2002","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.hoc.2010.06.003_bib131","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.hoc.2010.06.003_bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-5945-8-1","article-title":"Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model","volume":"8","author":"Rauktys","year":"2008","journal-title":"BMC Dermatol"},{"issue":"3","key":"10.1016\/j.hoc.2010.06.003_bib133","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.hoc.2010.06.003_bib134","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1053\/j.ajkd.2006.05.018","article-title":"Antitumoral activity of rapamycin in\u00a0renal angiomyolipoma associated with tuberous sclerosis complex","volume":"48","author":"Wienecke","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.hoc.2010.06.003_bib135","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hoc.2010.06.003_bib136","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archderm.1987.01660260111026","article-title":"Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases","volume":"123","author":"Kraemer","year":"1987","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.hoc.2010.06.003_bib137","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/archderm.1994.01690080084012","article-title":"The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm","volume":"130","author":"Kraemer","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.hoc.2010.06.003_bib138","series-title":"GeneReviews","article-title":"Xeroderma pigmentosum","author":"Kraemer","year":"2008"},{"issue":"4","key":"10.1016\/j.hoc.2010.06.003_bib139","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.neuroscience.2006.12.020","article-title":"Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship","volume":"145","author":"Kraemer","year":"2007","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.hoc.2010.06.003_bib140","first-page":"349","article-title":"Early-onset of sporadic basal-cell carcinoma: germline mutations in the TP53, PTCH, and XPD genes","volume":"26","author":"Su\u00e1rez-Mart\u00ednez","year":"2007","journal-title":"P\u00a0R Health Sci J"},{"issue":"4","key":"10.1016\/j.hoc.2010.06.003_bib141","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/humu.20158","article-title":"Polymorphism in the nuclear excision repair gene ERCC2\/XPD: association between an exon 6-exon 10 haplotype and susceptibility to cutaneous basal cell carcinoma","volume":"25","author":"Lovatt","year":"2005","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib142","first-page":"77","article-title":"Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma","volume":"8","author":"Dybdahl","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.hoc.2010.06.003_bib143","series-title":"GeneReviews","article-title":"Dyskeratosis congenita","author":"Savage","year":"2009"},{"key":"10.1016\/j.hoc.2010.06.003_bib144","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mad.2007.11.002","article-title":"The role of telomere biology in bone marrow failure and other disorders","volume":"129","author":"Savage","year":"2008","journal-title":"Mech Ageing Dev"},{"issue":"2","key":"10.1016\/j.hoc.2010.06.003_bib145","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2141.2009.07598.x","article-title":"Advances in the understanding of dyskeratosis congenita","volume":"145","author":"Walne","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2010.06.003_bib146","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-genom-082908-150046","article-title":"Syndromes of telomere shortening","volume":"10","author":"Armanios","year":"2009","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"6","key":"10.1016\/j.hoc.2010.06.003_bib147","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/sj.bjc.6603934","article-title":"Genetic variation in five genes important in telomere biology and risk for breast cancer","volume":"97","author":"Savage","year":"2007","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.hoc.2010.06.003_bib148","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng.296","article-title":"Sequence variants at the TERT-CLPTM1L locus associate with many cancer types","volume":"41","author":"Rafnar","year":"2009","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.hoc.2010.06.003_bib149","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.lungcan.2009.02.005","article-title":"Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility","volume":"66","author":"Hosgood","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.hoc.2010.06.003_bib150","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1182\/blood-2007-02-075598","article-title":"Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita","volume":"110","author":"Alter","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2010.06.003_bib151","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.hoc.2009.01.003","article-title":"Dyskeratosis congenita","volume":"23","author":"Savage","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"issue":"3","key":"10.1016\/j.hoc.2010.06.003_bib152","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.hoc.2009.03.010","article-title":"Melanoma epidemiology","volume":"23","author":"Tucker","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"10.1016\/j.hoc.2010.06.003_bib153","first-page":"225","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hoc.2010.06.003_bib154","series-title":"Cancer epidemiology and prevention","first-page":"1196","article-title":"Cutaneous and ocular melanoma","author":"Gruber","year":"2006"},{"key":"10.1016\/j.hoc.2010.06.003_bib155","series-title":"Cutaneous melanoma","first-page":"1","article-title":"A\u00a0history of melanoma: from Hunter to Clark","author":"McLead","year":"2003"},{"issue":"5","key":"10.1016\/j.hoc.2010.06.003_bib156","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archderm.1978.01640170032006","article-title":"Origin of familial malignant melanomas from heritable melanocytic lesions. \u2018The B-K mole syndrome\u2019","volume":"114","author":"Clark","year":"1978","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.hoc.2010.06.003_bib157","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/jmg.15.5.352","article-title":"Familial atypical multiple mole-melanoma syndrome","volume":"15","author":"Lynch","year":"1978","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.hoc.2010.06.003_bib158","series-title":"Genetic predisposition to cancer","first-page":"352","article-title":"Familial melanoma and its management","author":"Goldstein","year":"2004"},{"issue":"28","key":"10.1016\/j.hoc.2010.06.003_bib159","doi-asserted-by":"crossref","first-page":"7168","DOI":"10.1200\/JCO.2005.11.999","article-title":"Population-based analysis of prognostic factors and survival in familial melanoma","volume":"23","author":"Florell","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0994-15","article-title":"Germline p16 mutations in familial melanoma","volume":"8","author":"Hussussian","year":"1994","journal-title":"Nat Genet"},{"issue":"5157","key":"10.1016\/j.hoc.2010.06.003_bib161","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.8153634","article-title":"A\u00a0cell cycle regulator potentially involved in genesis of many tumor types","volume":"264","author":"Kamb","year":"1994","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib162","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ng0595-114","article-title":"Mutations associated with familial melanoma impair p16INK4 function","volume":"10","author":"Ranade","year":"1995","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib163","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng0196-97","article-title":"Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma","volume":"12","author":"Zuo","year":"1996","journal-title":"Nat Genet"},{"issue":"20","key":"10.1016\/j.hoc.2010.06.003_bib164","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1038\/sj.onc.1206445","article-title":"Genetics of melanoma predisposition","volume":"22","author":"Hayward","year":"2003","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.hoc.2010.06.003_bib165","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/jnci\/92.12.1006","article-title":"Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations","volume":"92","author":"Goldstein","year":"2000","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.hoc.2010.06.003_bib166","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/hmg\/7.2.209","article-title":"Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group","volume":"7","author":"Soufir","year":"1998","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.003_bib167","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/gcc.20202","article-title":"A\u00a0large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation","volume":"44","author":"Molven","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.hoc.2010.06.003_bib168","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/gcc.20518","article-title":"Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas","volume":"47","author":"Helsing","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"10.1016\/j.hoc.2010.06.003_bib169","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/humu.9247","article-title":"Familial melanoma, pancreatic cancer and germline CDKN2A mutations","volume":"23","author":"Goldstein","year":"2004","journal-title":"Hum Mutat"},{"issue":"3","key":"10.1016\/j.hoc.2010.06.003_bib170","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.jid.5700094","article-title":"Population-based prevalence of CDKN2A mutations in Utah melanoma families","volume":"126","author":"Eliason","year":"2006","journal-title":"J\u00a0Invest Dermatol"},{"issue":"10","key":"10.1016\/j.hoc.2010.06.003_bib171","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1200\/JCO.1999.17.10.3245","article-title":"Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: a consensus statement of the melanoma genetics consortium","volume":"17","author":"Kefford","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2010.06.003_bib172","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jmg.2006.043802","article-title":"Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents","volume":"44","author":"Goldstein","year":"2007","journal-title":"J\u00a0Med Genet"},{"issue":"20","key":"10.1016\/j.hoc.2010.06.003_bib173","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.1158\/0008-5472.CAN-06-0494","article-title":"High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL","volume":"66","author":"Goldstein","year":"2006","journal-title":"Cancer Res"},{"issue":"15","key":"10.1016\/j.hoc.2010.06.003_bib174","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/92.15.1260","article-title":"High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families","volume":"92","author":"Borg","year":"2000","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2010.06.003_bib175","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1086\/377140","article-title":"Localization of a novel melanoma susceptibility locus to 1p22","volume":"73","author":"Gillanders","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.hoc.2010.06.003_bib176","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1001\/archderm.139.6.816","article-title":"Identification of novel deletion loci at 1p36 and 9p22-21 in melanocytic dysplastic nevi and cutaneous malignant melanomas","volume":"139","author":"Hussein","year":"2003","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1016\/j.hoc.2010.06.003_bib177","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/jnci\/94.12.894","article-title":"Geographical variation in the penetrance of CDKN2A mutations for melanoma","volume":"94","author":"Bishop","year":"2002","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"20","key":"10.1016\/j.hoc.2010.06.003_bib178","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/jnci\/dji312","article-title":"Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample","volume":"97","author":"Begg","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.hoc.2010.06.003_bib179","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/sj.jid.5700689","article-title":"CDKN2A germline mutations in individuals with cutaneous malignant melanoma","volume":"127","author":"Orlow","year":"2007","journal-title":"J\u00a0Invest Dermatol"},{"issue":"5","key":"10.1016\/j.hoc.2010.06.003_bib180","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/jmg.2007.055376","article-title":"CDKN2A mutations and melanoma risk in the Icelandic population","volume":"45","author":"Goldstein","year":"2008","journal-title":"J\u00a0Med Genet"},{"issue":"5","key":"10.1016\/j.hoc.2010.06.003_bib181","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/humu.20476","article-title":"Comprehensive evaluation of allele frequency differences of MC1R variants across populations","volume":"28","author":"Gerstenblith","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.hoc.2010.06.003_bib182","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev.genet.37.110801.143233","article-title":"Genetics of hair and skin color","volume":"37","author":"Rees","year":"2003","journal-title":"Annu Rev Genet"},{"issue":"12","key":"10.1016\/j.hoc.2010.06.003_bib183","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/ijc.23396","article-title":"MC1R variants, melanoma and red hair color phenotype: a meta-analysis","volume":"122","author":"Raimondi","year":"2008","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.hoc.2010.06.003_bib184","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/ng.161","article-title":"ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma","volume":"40","author":"Gudbjartsson","year":"2008","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.hoc.2010.06.003_bib185","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.163","article-title":"Common sequence variants on 20q11.22 confer melanoma susceptibility","volume":"40","author":"Brown","year":"2008","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.hoc.2010.06.003_bib186","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ng.410","article-title":"Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi","volume":"41","author":"Falchi","year":"2009","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.hoc.2010.06.003_bib187","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/ng.411","article-title":"Genome-wide association study identifies three loci associated with melanoma risk","volume":"41","author":"Bishop","year":"2009","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.hoc.2010.06.003_bib188","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1158\/1055-9965.EPI-04-0777","article-title":"Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees","volume":"14","author":"Chaudru","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1016\/j.hoc.2010.06.003_bib189","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1086\/323412","article-title":"MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations","volume":"69","author":"Box","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.hoc.2010.06.003_bib190","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1158\/1055-9965.EPI-05-0321A","article-title":"Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations","volume":"14","author":"Goldstein","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1016\/j.hoc.2010.06.003_bib191","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/323411","article-title":"Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma","volume":"69","author":"van der Velden","year":"2001","journal-title":"Am J\u00a0Hum Genet"},{"issue":"4","key":"10.1016\/j.hoc.2010.06.003_bib192","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jaad.2009.03.016","article-title":"Selection criteria for genetic assessment of patients with familial melanoma","volume":"61","author":"Leachman","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.hoc.2010.06.003_bib193","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(02)00894-X","article-title":"Genetic testing for melanoma","volume":"3","author":"Kefford","year":"2002","journal-title":"Lancet Oncol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858810000924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858810000924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:55:18Z","timestamp":1760183718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858810000924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":193,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0889858810000924"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2010.06.003","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hereditary Genodermatoses with Cancer Predisposition","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2010.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}